血糖儀（BGM）市場規模、佔有率和成長分析：按設備類型、測量方法、連接方式、應用、最終用戶和地區分類 - 產業預測，2026-2033年

2024 年全球血糖監測 (BGM) 設備市場價值為 52 億美元，預計到 2025 年將成長至 55.5 億美元，到 2033 年將成長至 94.1 億美元，在預測期（2026-2033 年）內複合年成長率為 6.8%。

全球血糖監測（BGM）設備市場的發展動力源於對精準血糖值測量的迫切需求，這對於數百萬糖尿病成人患者的有效血糖管理至關重要。隨著糖尿病患者人數的持續成長，對血糖監測設備的需求也不斷擴大。市場正迅速從笨重的實驗室設備轉向先進的、與智慧型手機相容的設備，例如雅培Accu-Chek和FreeStyle Libre。與醫療保健生態系統的整合促進了數據共用，並改善了患者的治療效果，從而促使醫療服務提供者和保險公司採用這些技術。此外，人工智慧的整合正在革新血糖監測技術，透過預測演算法和直覺的介面來提高測量精度和用戶體驗。最終，更智慧、更互聯的設備不僅能夠緩解患者的焦慮，還能增強醫療專業人員的洞察力，實現個人化護理，並加速向訂閱模式的轉變。

全球血糖儀（BGM設備）市場成長要素

隨著全球糖尿病盛行率的上升，患者積極尋求即時血糖值資訊以有效管理病情，這導致對便利式自我監測設備的需求日益成長。醫療專業人員建議定期檢測以改善血糖控制，並推廣使用攜帶式血糖儀。人們對有效疾病管理益處的認知不斷提高，推動了設備精度和使用者體驗的持續改進，進一步促進了市場成長。消費者和醫療服務提供者都強調了可靠監控解決方案的重要性。此外，監管機構對以患者為中心的護理的支持，也強化了這一趨勢，並促進了市場的持續發展。

全球血糖監測（BGM設備）市場的限制因素

全球血糖儀市場面臨諸多挑戰，限制了其在消費者中的廣泛普及，尤其是一些具備連續監測和整合連接功能的高階型號價格相對較高。在許多地區，保險報銷不足以涵蓋高階設備的費用，迫使患者選擇基礎型血糖儀或其他監測方法。這種經濟上的顧慮阻礙了對新技術的投資，儘管這些新技術具有臨床優勢，但也減緩了市場滲透速度。因此，製造商需要在創新和價格可負擔之間找到平衡，才能有效吸引價格敏感型消費者，並降低成長障礙。

全球血糖儀（BGM設備）市場趨勢

全球血糖監測（BGM）設備市場正呈現建構互聯醫療生態系統的顯著趨勢。這一趨勢強調將血糖儀與智慧型手機和雲端平台整合，從而實現即時數據共用和遠端患者監護。這些進步使臨床醫生能夠快速調整治療方案，並為每位患者提供個人化的生活方式建議。藍牙、近場通訊（NFC）和人工智慧（AI）分析等技術的引入，將原始血糖值數據轉化為有價值的洞察，從而提高患者的依從性。此外，這種整合還透過基於訂閱的醫療保健服務和數據驅動的夥伴關係開闢了新的收入來源，最終目標是改善全球健康狀況並減少住院治療。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球血糖儀（BGM設備）市場規模：按設備類型分類

• 標準背景音樂
• 智慧背景音樂
• 連續血糖監測儀

全球血糖儀（BGM設備）市場規模：依測量方法分類

• 條
• 無需脫衣

全球血糖監測（BGM）設備市場規模：依連接等級分類

• Bluetooth
• Wi-Fi
• 細胞

全球血糖儀（BGM 設備）市場規模：按應用領域分類。

• 1型糖尿病
• 2型糖尿病

全球血糖儀（BGM設備）市場規模：依最終用戶分類

• 醫院和診所
• 診斷中心
• 居家照護

全球血糖儀（BGM設備）市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Ascensia Diabetes Care
• LifeScan, Inc.
• ARKRAY, Inc.
• Bayer AG
• AgaMatrix, Inc.
• Trividia Health, Inc.
• Nipro Corporation
• Terumo Corporation
• i-SENS, Inc.
• Sinocare Inc.
• Ypsomed AG
• Dexcom, Inc.
• Medtronic plc
• A. Menarini Diagnostics Srl
• TaiDoc Technology Corporation
• Nova Biomedical
• 77 Elektronika Kft.
• B. Braun SE

結論與建議

Global Blood Glucose Meters (Bgm) Devices Market size was valued at USD 5.2 Billion in 2024 and is poised to grow from USD 5.55 Billion in 2025 to USD 9.41 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global blood glucose meters (BGM) market is driven by the critical need for accurate blood sugar measurement, essential for effective diabetes management among millions of adults living with the condition. With an expected increase in diabetic patients, the demand for BGMs continues to grow. The market has rapidly transitioned from bulky laboratory devices to advanced, smartphone-compatible meters, demonstrated by products like Accu-Chek and FreeStyle Libre. Integrating health ecosystems fosters data sharing that enhances patient outcomes, compelling providers and payers to embrace these technologies. Additionally, AI integration is revolutionizing BGMs by improving measurement accuracy and user experience through predictive algorithms and intuitive interfaces, resulting in smarter, connected devices that alleviate patient anxiety while augmenting clinician insights for tailored care and fostering a shift toward subscription-based models.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Glucose Meters (Bgm) Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Glucose Meters (Bgm) Devices Market Segments Analysis

Global blood glucose meters (bgm) devices market is segmented by meter type, testing method, connectivity, application, end user and region. Based on meter type, the market is segmented into Standard Blood Glucose Meters, Smart Blood Glucose Meters and Continuous-Connected Glucose Meters. Based on testing method, the market is segmented into Strip-Based and Strip-Free. Based on connectivity, the market is segmented into Bluetooth, Wi-Fi and Cellular. Based on application, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on end user, the market is segmented into Hospitals & Clinics, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Glucose Meters (Bgm) Devices Market

The increasing prevalence of diabetes globally is fueling the demand for convenient self-monitoring devices, as patients actively seek real-time glucose information for effective management of their condition. Healthcare professionals advocate for regular testing to enhance glycemic control, promoting the use of portable glucose meters. This growing awareness of the advantages of effective disease management drives continuous advancements in device precision and user experience, further propelling market growth. Both consumers and healthcare providers emphasize the importance of dependable monitoring solutions. Moreover, regulatory support for patient-centered care reinforces this trend across various healthcare environments, contributing to ongoing market development.

Restraints in the Global Blood Glucose Meters (Bgm) Devices Market

The Global Blood Glucose Meters (BGM) Devices market faces challenges due to the relatively high prices of advanced models, especially those with continuous monitoring capabilities and integrated connectivity, which restrict broad consumer adoption. In many regions, reimbursement policies do not adequately support the cost of premium devices, leading patients to opt for basic glucose meters or alternative monitoring methods. This financial sensitivity discourages investment in newer technologies, despite their potential clinical advantages, resulting in slower market penetration. Thus, manufacturers are compelled to find a balance between innovation and affordability to effectively engage price-sensitive consumers and alleviate this barrier to growth.

Market Trends of the Global Blood Glucose Meters (Bgm) Devices Market

The Global Blood Glucose Meters (BGM) Devices market is witnessing a significant trend towards the creation of a connected-care ecosystem. This trend emphasizes the integration of blood glucose meters with smartphones and cloud platforms, facilitating real-time data sharing and remote patient monitoring. Such advancements allow clinicians to promptly adjust therapies and deliver personalized lifestyle recommendations. The incorporation of technologies like Bluetooth, NFC, and AI-driven analytics transforms raw glucose readings into valuable insights, enhancing patient compliance. Additionally, this integration opens new revenue avenues through subscription-based health services and data-driven partnerships, ultimately aiming to improve health outcomes and reduce hospitalizations on a global scale.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Blood Glucose Meters (BGM) Devices Market Size by Meter Type & CAGR (2026-2033)

• Market Overview
• Standard Blood Glucose Meters
• Smart Blood Glucose Meters
• Continuous-Connected Glucose Meters

Global Blood Glucose Meters (BGM) Devices Market Size by Testing Method & CAGR (2026-2033)

• Market Overview
• Strip-Based
• Strip-Free

Global Blood Glucose Meters (BGM) Devices Market Size by Connectivity & CAGR (2026-2033)

• Market Overview
• Bluetooth
• Wi-Fi
• Cellular

Global Blood Glucose Meters (BGM) Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Blood Glucose Meters (BGM) Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Diagnostic Centers
• Homecare

Global Blood Glucose Meters (BGM) Devices Market Size & CAGR (2026-2033)

• North America (Meter Type, Testing Method, Connectivity, Application, End User)
  • US
  • Canada
• Europe (Meter Type, Testing Method, Connectivity, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Meter Type, Testing Method, Connectivity, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Meter Type, Testing Method, Connectivity, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Meter Type, Testing Method, Connectivity, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• i-SENS, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• A. Menarini Diagnostics S.r.l.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TaiDoc Technology Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 77 Elektronika Kft.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations